Literature DB >> 10656941

Transesophageal echocardiographic assessment of hemodynamic function during laparoscopic cholecystectomy in healthy patients.

D D'Ugo1, R Persiani, F Pennestri, E Adducci, P Primieri, V Pende, G De Cosmo.   

Abstract

BACKGROUND: This study aimed by means of transesophageal echocardiography, to evaluate hemodynamic changes induced by pneumoperitoneum in patients with normal cardiac performance.
METHODS: In this study, 11 ASA I-II patients (mean age, 39 years) with normal cardiac performance undergoing laparoscopic cholecystectomy were evaluated. A 5-MHz transesophageal biplane phased-array transducer connected to an echocardiographer was inserted after induction of anesthesia. Data were collected at three different times: before insufflation (T1), 10 min after insufflation (T2), and 5 min after desufflation (T3). At these same times, heart rate, systolic blood pressure, diastolic blood pressure, end-tidal carbon dioxide (CO(2)), and peak airway pressure were recorded. Statistical analysis was performed using one-way and two-way analysis of variance (ANOVA). A p value less than 0.05 was considered significant.
RESULTS: End-systolic and end-diastolic diameters of the left ventricle, contractility, and performance parameters did not change significantly. Conversely, at insufflation, color Doppler area of the mitral backflow increased significantly (p < 0.05) when already present or showed up abruptly (T1: 0.22 +/- 0.28 cm(2); T2: 1.28 +/- 1.02 cm(2); T3: 0.49 +/- 0.53 cm(2)).
CONCLUSIONS: Such an event is not interpreted as a mitral insufficiency. It is possibly the result of a "contrast effect" caused by the absorption of CO(2) microbubbles in the blood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656941     DOI: 10.1007/s004649900080

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  1 in total

Review 1.  The physiologic effects of pneumoperitoneum in the morbidly obese.

Authors:  Ninh T Nguyen; Bruce M Wolfe
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.